Toksoplazmoz Tanısı

Toksoplazmoz, Apikompleksan bir protozoon olan Toxoplasma gondii’nin etken olduğu bir paraziter hastalıktır. İmmunkompetan kişilerde çoğunlukla asemptomatik, kendini sınırlayan nezle benzeri bir tablo veya lokal lenfadenopati ile seyrederken; immun yetmezliği olanlarda ve enfekte fetus veya yenidoğanlarda ölümle sonuçlanabilen ağır tablolara yol açabilmektedir. Histolojik tanı veya organizmanın izolasyonu zor ve zaman alıcı olduğu için, tanıda esas olarak serolojik tanı yöntemleri kullanılmaktadır. Bu derlemede, toksoplazmoz tanısında değişik hasta gruplarında kullanılabilecek antikor tipleri ve serolojik yöntemler gözden geçirilmiştir. Özellikle toksoplazmoz tanısının önemli ama zor olduğu gebeler ve yeni doğanlarda öne çıkan bazı yeni ve geliştirilmiş tanı yöntemlerinden bahsedilmiş ve serolojik testlerin yorumlanmasında karşılaşılabilecek sorunlar özetlenmiştir.

Diagnosis of toxoplasmosis

Toxoplasmosis is a parasitic disease caused by the Apicomplexan protozoan Toxoplasma gondii. Toxoplasmosis is generally asymptomatic or characterized either with regional lymphadenopathy or a fl u-like illness in immunocompetant patients. On the other hand , it can have deleterious effects with fetal consequences on fetuses, newborns and immunocompromised patients. As histological diagnosis and isolation from tissues is labor-intensive, time-consuming and less sensitive than indirect diagnostic methods, serology became the main diagnostic choice in toxoplasmosis. Antibody types and diff erent serological methods which are suitable for the diagnosis of toxoplasmosis in diff erent patient groups were reviewed. Some new and improved immunological techniques used for the detection of toxoplasmosis in pregnant women and newborns were summarized and the problems due to the diff iculty of interpretation of serological results were discussed.

___

  • 1. Dubey JP. Toxoplasmosis. In: Cox FEG, Kreier JP, Wakelin D, editors. Topley & Wilson’s Microbiology and Microbial Infections. Vol.5 Parasitology Vol. 9th ed. Arnold Press; 1998. p.303-318.
  • 2. Kim K, Weiss LM. Toxoplasma gondii: the model apicomplexan. Int J Parasitol 2004;34:423-432.
  • 3. Dubey JP, Lindsay DS, Speer CA. Structures of Toxoplasma gondii tachyzoits, bradyzoits, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev 1998;11:267-299.
  • 4. Sibley LD, Boothroyd JC. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 1982;359:82-85.
  • 5. Cook AJ, Gilbert RE, Holland FJ et al. Sources of Toxoplasma infection in pregnant women: European multicenter casecontrol study. European Research Network on Congenital Toxoplasmosis. Br Med J 2000;321:142-147.
  • 6. Altıntaş N, Yolasığmaz A, Yazar S, ve ark. İzmir ve çevresindeki yerleşim bölgelerinde yaşayan insanlarda Toxoplasma antikorlarının araştırılması. Türkiye Parazitol Derg 1998;21:245-247.
  • 7. Davaro RF, Th irumalai A. Life-threatening complications of HIV infection. J Intensive Care Med 2007;22:73-81.
  • 8. Campbell AL, Goldberg CL, Magid MS et al. First case of toxoplasmosis following small bowel transplantation and systematic review of tissue-invasive toxoplasmosis following noncardiac solid organ transplantation. Transplantation 2006; 81:408-17
  • 9. Dodds EM. Toxoplasmosis. Curr Opin Ophthalmol 2006;17:557-61.
  • 10. Petersen E. Toxoplasmosis. Seminars in Fetal and Neonatal Medicine 2007;12:214-223.
  • 11. Kaul R, Chen P, Binder SR. Detection of Immunoglobulin M antibodies specifi c for Toxoplasma gondii with increased selectivity for recently aquired infections. J Clin Microbiol 2004;42:5705-5709.
  • 12. Svobodova V, Literak I. Prevalence of IgM and IgG antibodies to Toxoplasma gondii in blood donors in Czech Republic. Eur J Epidemiol 1998;14:803-805.
  • 13. Jones J, Lopez A, Wilson M. Congenital toxoplasmosis. Am Fam Physician 2003;67:2131-2138.
  • 14. Meeting report. Th e VIIIth International Congress on Toxoplasmosis. Microb Infect 2006;8:1979-1983.
  • 15. Montoya JG. Diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis 2002;185(Suppl1):S73-82.
  • 16. Garcia LS. Protozoa from other sites. Diagnostic Medical Parasitology. 5th ed. Washington, D.C.:ASM Press; 2007. p.123-141.
  • 17. Reiter-Owona I, Petersen E, Joynson D, et al. Th e past and present role of Sabin-Feldman dye test in the serodiagnosis of toxoplasmosis. Bull World Health Organ 1999;77:929-935.
  • 18. Rigsby P, Rijpkema S, Guy EC, Francis J, Das RG. Evaluation of candidate international standard preparation for human anti-Toxoplasma immunoglobulin G. J Clin Microbiol 2004;42:5133-5138.
  • 19. Meek B, Gool TV, Gilis H, Peek R. Dissecting the IgM response during the acute and latent phase of toxoplasmosis. Diagn Microbiol Infect Dis 2001;41:131-137.
  • 20. Ashburn D, Joss AW, Pennington TH, Ho-Yen DO. Do IgA, IgE and IgG avidity tests have any value in the diagnosis of Toxoplasma infection in pregnancy? J Clin Pathol 1998;51:312-315.
  • 21. Wong S, Hadju M, Ramirez R, Th ulliez P, McLeod R, Remington JS. Role of specifi c immunoglobulin E in diagnosis of acute Toxoplasma infection and toxoplasmosis. J Clin Microbiol 1993;31:2952-2959.
  • 22. Sabin AB, Feldman HA. Dyes as microchemical indicators of a new immunity phenomenon aff ecting a protozoan para site (Toxoplasma). Science 1948;108:660-663.
  • 23. Danneman B, Vaughn W, Th ulliez P, Remington JS. Diff erential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii. J Clin Microbiol 1990;28:1928-1933.
  • 24. Naot Y, Remington J. An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii : use for diagnosis of acute acquired toxoplasmosis. J Infect Dis 1980;142:757-766.
  • 25. Desmonts G, Naot Y, Remington JS. Immunoglobulin M immunosorbent agglutination assay for diagnosis of acute congenital and acquired Toxoplasma infections. J Clin Microbiol 1981;14:486-491.
  • 26. Hedman K, Lappalainen M, Seppala I, et al. Recent primary Toxoplasma infection indicated by a low avidity of specifi c IgG. J Infect Dis 1989;159:736-739.
  • 27. Montoya JG, Huff man HB, Remington JS. Evaluation of the immunoglobulin G test for the diagnosis of toxoplasmic lymphadenopathy. J Clin Microbiol 2004;42:4627-4631.
  • 28. Lappalainen M, Hedman K. Serodiagnosis of toxoplasmosis. Th e impact of measurement of IgG avidity. Ann Ist Super Sanita 2004;40:81-88.
  • 29. Liesenfeld O, Montoya JG, Kinney S, et al. Eff ect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis 2001;183:1248-1253.
  • 30. Wilson M, Remington JS, Clavet C, et al. Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma gondii. J Clin Microbiol 1997;35:3112-3115.
  • 31. Remington JS, Th ulliez P, Montoya JG. Recent development for diagnosis of toxoplasmosis. J Clin Microbiol 2004;42:941-945.
  • 32. Remington JS, Araujo FG, Desmonts G. Recognition of diff erent Toxoplasma antigensby IgG and IgM antibodies in mothers and their congenitally infected newborns. J Infect Dis 1985;152:1020-1024.
  • 33. Liesenfeld O, Montoya JG, Tathineni NJ, et al. Confi rmatory serologic testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers. Am J Obstet Gynecol 2001;184:140-145.
  • 34. Reiter-Owona I. Laboratory diagnosis of toxoplasmosis-possibilities and limitations. J Lab Med 2005;29:439-445.
  • 35. Chabbert E, Lachaud L, Crobu L, et al. Comparison of two widely used PCR primer systems for detection of Toxoplasma in amniotic fl uid, blood and tissues. J Clin Microbiol 2004;42:1719-1722.
  • 36. Filisetti D, Gorcii M, Pernot-Marino E, et al. Diagnosis of congenital toxoplasmosis: comparison of targets for detection of Toxoplasma gondii by PCR. J Clin Microbiol 2003;41:4826-4828.
  • 37. Hohlfeld P, Daff os F, Costa JM, et al. Prenatal diagnosis of congenital toxoplasmosis with PCR test on amniotic fl uid. N Engl J Med 1994;331:695-699.
  • 38. Costa JM, Pautas P, Ernault F, et al. Real time PCR for diagnosis and follow up of toxoplasma reactivation after allogeneic stem cell transplantation using fl uorescence resonance energy transfer hybridization probes. J Clin Microbiol 2000;38:2929-2932.
  • 39. Bulaşıcı hastalıkların ihbarı ve bildirim sistemi, Standart tanı, sürveyans ve laboratuvar rehberi. 4th ed. Ankara; 2005. p.115-116, p.249-250.